Red Light Therapy for Pets with Chronic Kidney Disease: A New Hope?

Chronic Kidney Disease (CKD) is one of the most common, frustrating, and heartbreaking conditions affecting our pets, especially senior cats and dogs. The kidneys slowly lose function over time, leading to toxin buildup, appetite loss, dehydration, weakness, and ultimately, a diminished quality of life.

Traditional treatments—special diets, fluids, medications—help slow the disease but can’t reverse the damage. Which leads us to an important question:

Can red light therapy make a real difference in pets with CKD?

Recent research suggests: it just might (PBM and CKD 2024).

---

Understanding Chronic Kidney Disease and Red Light Therapy

Chronic Kidney Disease is a progressive loss of kidney function lasting more than three months. It’s often driven by mitochondrial dysfunction, oxidative stress, chronic inflammation, and even changes in the gut microbiome.

Photobiomodulation therapy (PBM), commonly known as red light therapy, uses specific wavelengths of red and near-infrared light (typically 600–800+ nm) to stimulate healing at the cellular level (Hamblin, 2017). It’s already been used successfully for musculoskeletal injuries, neurological conditions, wound healing, and pain management in pets.

In the case of CKD, PBM may help by:

• Stimulating mitochondrial function and ATP production, improving energy at the cellular level (Anders, 2018)
• Reducing oxidative stress by boosting antioxidant activity
• Decreasing inflammation by modulating inflammatory cytokines (Hamblin, 2017)
• Potentially improving gut health, indirectly supporting kidney function (PBM and CKD 2023)

While we don’t fully understand every mechanism yet, the science points toward multiple supportive pathways—and the clinical results are starting to back it up.

How does it work?

• PBM uses red and near-infrared light (600–800+ nm) to stimulate mitochondrial function, reduce oxidative stress, and decrease inflammation (Hamblin, 2018).
• CKD progression involves mitochondrial dysfunction, oxidative stress, inflammation, and gut dysbiosis—all proposed targets of PBM.
• Early clinical data suggests PBM improves quality of life and stabilizes renal parameters in pets with CKD.
• Current clinical studies, including those using MedcoVet’s Luma, are actively investigating these effects.

---

Prove It: Research Highlights

• A pilot study presented at ASLMS in 2016 treated 12 pets (dogs and cats) with Stage III–IV CKD using PBM alongside traditional care. Ten of the twelve survived over a year with “very good to excellent” quality of life (PBM and CKD 2023).
• Private veterinary clinics have since replicated these results, seeing marked improvements in appetite, energy, and lab parameters like BUN and creatinine stability (PBM and CKD 2024).
• A current clinical study (launched in 2023) is evaluating at-home PBM treatment using the Luma in cats with CKD. Interim findings (as of February 2024) show:
  • 65% of pet owners report improved appetite and/or activity
  • 33% of pets show improved blood markers (Creatinine, BUN, Phosphorus)
  • Earlier-stage CKD patients show the greatest stabilization (PBM and CKD 2024)
• Proposed mechanisms include enhanced mitochondrial function, reduced oxidative stress, modulation of inflammatory pathways, and improved comfort and energy—all critical in supporting CKD management (Hamblin, 2017).

You can dive deeper into the clinical updates here:

• Photobiomodulation Laser Therapy and Chronic Kidney Disease (2024)
• Photobiomodulation and Red Light Therapy for CKD (2023)

---

Final Takeaway

Light therapy won’t “cure” CKD. But for aging pets facing this difficult disease, it’s offering something invaluable: a non-invasive, stress-free way to support better appetite, more energy, less discomfort, and possibly a longer, higher-quality life.

At MedcoVet, we’re proud that our Luma device is part of the clinical research shaping the future of at-home care for CKD—and we’re even prouder to help pets (and their people) find hope in the process.

---

Sources and References

• Anti-inflammatory Effects of PBM – Hamblin (2017)
• Photobiomodulation Laser Therapy and Chronic Kidney Disease
• Photobiomodulation and Red Light Therapy and Chronic Kidney Disease
• Review of light parameters and photobiomodulation efficacy: Dive into complexity,Hamblin et al.